8uo8

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (10:07, 25 December 2024) (edit) (undo)
 
(One intermediate revision not shown.)
Line 10: Line 10:
== Function ==
== Function ==
[https://www.uniprot.org/uniprot/SV2B_HUMAN SV2B_HUMAN] Probably plays a role in the control of regulated secretion in neural and endocrine cells. (Microbial infection) Receptor for the C.botulinum neurotoxin type A2 (BoNT/A, botA); glycosylation is not essential but enhances the interaction (PubMed:29649119). Probably also serves as a receptor for the closely related C.botulinum neurotoxin type A1.<ref>PMID:29649119</ref> <ref>PMID:29649119</ref>
[https://www.uniprot.org/uniprot/SV2B_HUMAN SV2B_HUMAN] Probably plays a role in the control of regulated secretion in neural and endocrine cells. (Microbial infection) Receptor for the C.botulinum neurotoxin type A2 (BoNT/A, botA); glycosylation is not essential but enhances the interaction (PubMed:29649119). Probably also serves as a receptor for the closely related C.botulinum neurotoxin type A1.<ref>PMID:29649119</ref> <ref>PMID:29649119</ref>
 +
<div style="background-color:#fffaf0;">
 +
== Publication Abstract from PubMed ==
 +
Epilepsy is a common neurological disorder characterized by abnormal activity of neuronal networks, leading to seizures. The racetam class of anti-seizure medications bind specifically to a membrane protein found in the synaptic vesicles of neurons called synaptic vesicle protein 2 (SV2) A (SV2A). SV2A belongs to an orphan subfamily of the solute carrier 22 organic ion transporter family that also includes SV2B and SV2C. The molecular basis for how anti-seizure medications act on SV2s remains unknown. Here we report cryo-electron microscopy structures of SV2A and SV2B captured in a luminal-occluded conformation complexed with anticonvulsant ligands. The conformation bound by anticonvulsants resembles an inhibited transporter with closed luminal and intracellular gates. Anticonvulsants bind to a highly conserved central site in SV2s. These structures provide blueprints for future drug design and will facilitate future investigations into the biological function of SV2s.
 +
 +
Structures of synaptic vesicle protein 2A and 2B bound to anticonvulsants.,Mittal A, Martin MF, Levin EJ, Adams C, Yang M, Provins L, Hall A, Procter M, Ledecq M, Hillisch A, Wolff C, Gillard M, Horanyi PS, Coleman JA Nat Struct Mol Biol. 2024 Jun 19. doi: 10.1038/s41594-024-01335-1. PMID:38898101<ref>PMID:38898101</ref>
 +
 +
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
 +
</div>
 +
<div class="pdbe-citations 8uo8" style="background-color:#fffaf0;"></div>
== References ==
== References ==
<references/>
<references/>
Line 18: Line 27:
[[Category: Adams C]]
[[Category: Adams C]]
[[Category: Coleman JA]]
[[Category: Coleman JA]]
-
[[Category: Horyani PS]]
+
[[Category: Horanyi PS]]
[[Category: Ledecq M]]
[[Category: Ledecq M]]
[[Category: Levin E]]
[[Category: Levin E]]

Current revision

Structure of synaptic vesicle protein 2B with padsevonil

PDB ID 8uo8

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools